Franklin Resources Inc reports 0.10% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

IT ˙ BIT ˙ US92532F1003

366,30 € ↓ -1,30 (-0,35%)

2026-06-03
AKTIENPREIS

Security	IT:1VRTX / Vertex Pharmaceuticals Incorporated
Institution	Franklin Resources Inc
Latest Disclosed Ownership	551,132 shares
Latest Disclosed Value	$ 246,102,484

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 551,132 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $209,209,707 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 550,600 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.10% during the quarter. The current value of the position is $201,879,652 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-13	2026-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	551,132	532	0.10	246,102	-1.41	0.0603
2026-02-11	2025-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	550,600	87,646	18.93	249,620	37.68	0.0612
2025-11-13	2025-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	462,954	-60,879	-11.62	181,311	-22.25	0.0452
2025-08-12	2025-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	523,833	-178,201	-25.38	233,210	-31.48	0.0618
2025-05-13	2025-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	702,034	-58,483	-7.69	340,360	11.13	0.0979
2025-02-12	2024-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	760,517	283,684	59.49	306,260	32.48	0.0850
2024-11-27	2024-09-30	13F/A-1	VERTEX PHARMACEUTICALS	COM	92532F100	476,833	-75,581	-13.68	231,178	-10.72	0.0649
2024-11-12	2024-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	476,833	-75,581		231,178		0.0111
2024-08-14	2024-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	552,414	-150,645	-21.43	258,927	-11.90	0.0796
2024-05-13	2024-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	703,059	30,621	4.55	293,886	7.41	0.0931
2024-02-09	2023-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	672,438	-82,086	-10.88	273,608	4.28	0.1279
2023-11-13	2023-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	754,524	-77,014	-9.26	262,378	-10.34	0.1333
2023-08-11	2023-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	831,538	67,629	8.85	292,627	21.58	0.1391
2023-05-12	2023-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	763,909	-28,066	-3.54	240,685	5.24	0.1208
2023-02-10	2022-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	791,975	-140,876	-15.10	228,707	-15.32	0.1189
2022-11-14	2022-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	932,851	-58,108	-5.86	270,098	-3.27	0.1472
2022-08-11	2022-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	990,959	-133,797	-11.90	279,240	-4.87	0.1385
2022-05-13	2022-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,124,756	65,455	6.18	293,521	26.18	0.1173
2022-02-11	2021-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,059,301	192,377	22.19	232,629	47.94	0.0839
2021-11-12	2021-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	866,924	-251,473	-22.49	157,250	-30.27	0.0592
2021-08-13	2021-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,118,397	-45,280	-3.89	225,501	-9.82	0.0862
2021-05-13	2021-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,163,677	-116,400	-9.09	250,063	-17.34	0.1017
2021-02-10	2020-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,280,077	86,217	7.22	302,534	-6.88	0.1280
2020-11-12	2020-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,193,860	51,163	4.48	324,874	-2.38	0.1573
2020-08-13	2020-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,142,697	50,902	4.66	332,788	28.10	0.1714
2020-05-13	2020-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,091,795	-55,194	-4.81	259,793	3.45	0.1734
2020-03-11	2019-12-31	13F/A-1	VERTEX PHARMACEUTICALS	COM	92532F100	1,146,989	-100,879	-8.08	251,133	18.79	0.1319
2020-02-12	2019-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,146,989	-100,879		251,133		31,721.5362
2019-11-14	2019-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,247,868	170,686	15.85	211,414	7.03	0.1148
2019-08-14	2019-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,077,182	-82,941	-7.15	197,533	-7.44	0.1051
2019-05-15	2019-03-31	13F/A-1	VERTEX PHARMACEUTICALS	COM	92532F100	1,160,123	-53,371	-4.40	213,404	6.12	0.1143
2019-05-14	2019-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,160,123	-53,371		213,404
2019-02-12	2018-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,213,494	-22,441	-1.82	201,088	-15.59	0.1214
2018-11-13	2018-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,235,935	-54,820	-4.25	238,214	8.59	0.1186
2018-08-14	2018-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,290,755	163,689	14.52	219,377	19.43	0.1125
2018-05-10	2018-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,127,066	-123,926	-9.91	183,689	-2.02	0.0931
2018-02-14	2017-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,250,992	91,078	7.85	187,474	6.31	0.0900
2017-11-13	2017-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,159,914	18,376	1.61	176,353	19.88	0.0865
2017-08-10	2017-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,141,538	-51,910	-4.35	147,110	12.72	0.0734
2017-05-12	2017-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,193,448	-256,830	-17.71	130,504	22.15	0.0662
2017-02-14	2016-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,450,278	64,159	4.63	106,842	-11.62	0.0553
2016-11-14	2016-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,386,119	360,748	35.18	120,883	37.05	0.0632
2016-08-11	2016-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,025,371	35,356	3.57	88,202	12.08	0.0474
2016-05-10	2016-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	990,015	117,315	13.44	78,696	-28.34	0.0418
2016-04-27	2015-12-31	13F/A-1	VERTEX PHARMACEUTICALS	COM	92532F100	872,700	54,691	6.69	109,812	28.91	0.0556
2016-02-12	2015-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	872,700			109,812
2015-11-10	2015-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	818,009	-351,068	-30.03	85,188	-40.99	0.0421
2015-08-12	2015-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,169,077	222,100	23.45	144,357	29.22	0.0655
2015-05-14	2015-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	946,977	-12,329	-1.29	111,715	-1.97	0.0507
2015-02-10	2014-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	959,306	-162,867	-14.51	113,965	-9.57	0.0517
2014-11-12	2014-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,122,173	-349,585	-23.75	126,031	-9.56	0.0575
2014-08-12	2014-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,471,758	-301,215	-16.99	139,346	11.14	0.0614
2014-05-13	2014-03-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,772,973	236,208	15.37	125,384	9.81	0.0592
2014-02-12	2013-12-31	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,536,765	133,790	9.54	114,182	7.34	0.0558
2013-11-14	2013-09-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,402,975	102,000	7.84	106,374	2.37	0.0566
2013-08-09	2013-06-30	13F	VERTEX PHARMACEUTICALS	COM	92532F100	1,300,975	1,300,975		103,909		0.0593

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.